Subretinal Scarring
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD (NCT02599064) | RXi Pharmaceuticals, Corp. | 2015-11-01 |
Track Subretinal Scarring automatically
Every clearance here is in the API, with alerts when new ones post.